Category Specific RSS

News

Novatti granted regulatory approval to issue Visa cards in New Zealand

Fresh off the launch of their Digital Payments Accelerator, Australian fintech company Novatti Group (ASX: NOV) has been granted approval in New Zealand to expand its credit card issuing services. 

The approval for ‘issuing and managing means of payments’ in New Zealand will provide commercial opportunities for Novatti to extend services to existing clients in NZ which already utilise their suite of payments tech, billing and international remittance services. 

 “Novatti’s model is to build platforms that provide the ability to scale. Obtaining regulatory licencing is core to this strategy,” said Novatti Managing Director, Peter Cook. 

“Where possible, Novatti aims to offer complementary services to existing Australian customers with a presence in New Zealand, and to capitalise on the deep relationships that already exist in New Zealand through Novatti’s business process automation subsidiary, Emersion.” 

New Zealand is one of three countries Emersion already has a notable presence, the others being Australia and Singapore, and recently launched on the Salesforce AppExchange, offering small businesses with billing automation and subscription payment services capabilities. 

Registration with the New Zealand Companies Office Financial Service Providers Register is a natural fit for Novatti which holds a Visa Principal Issuer license from Visa Inc, enabling them to issue prepaid Visa cards both physically and digitally. This issuing division has seen a notable rise in adoption since the onset of COVID-19 where card usage has dramatically increased with many businesses ceased accepting cash while also sales towards online mediums where possible. 

Through this expanded license to operate in New Zealand, local businesses will soon be able to utilise Novatti’s Digital Payments Accelerator which facilitates the issuing of up to 2,500 custom-branded Visa cards where usage can be restricted to customisable situations. 

 

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago